CAPN3 and limb-girdle muscular dystrophy: However, this differential diagnosis enabled us to determine that six patients were candidates for gene-transfer therapies for LGMD (2 LGMD2D—SGCA, 2 LGMD2C—SGCG, 1 LGMD2E—SGCB and 1 LGMD2A—CAPN3).